We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.71B
1-Year Est. Return
65.19%
This Fund
S&P 500
This Quarter
Est. Return
+14.4%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$3.25B
AUM Growth
+$91M
(+2.9%)
Cap. Flow
-$180M
Cap. Flow
% of AUM
-5.53%
Top 10 Holdings %
Top 10 Hldgs %
17.1%
Holding
462
New
59
Increased
82
Reduced
124
Closed
93
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$36.3M |
| 2 |
Union Pacific
UNP
|
+$36.1M |
| 3 |
PVH
PVH
|
+$31.6M |
| 4 |
ServiceNow
NOW
|
+$26.6M |
| 5 |
Apple
AAPL
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$37.7M |
| 2 |
Citigroup
C
|
+$36.3M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$28.5M |
| 4 |
Monster Beverage
MNST
|
+$28.2M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$27.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.98% |
| 2 | Technology | 17.39% |
| 3 | Consumer Discretionary | 13.79% |
| 4 | Financials | 12.58% |
| 5 | Industrials | 12.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
SS&C Technologies
SSNC
$19.1B
| $5.88M | 0.18% |
113,236
-9,250
| -8% | -$468K |
|
|
LOXO
177
DELISTED
Loxo Oncology, Inc
LOXO
| $5.83M | 0.18% |
+33,595
| New | +$5.05M |
|
|
DENN
178
DELISTED
Denny's
DENN
| $5.8M | 0.18% |
364,210
+42,653
| +13% | +$678K |
|
179
Dolby
DLB
$5.65B
| $5.75M | 0.18% |
93,245
-7,625
| -8% | -$485K |
|
|
HES
180
DELISTED
Hess
HES
| $5.63M | 0.17% |
+84,200
| New | +$5.03M |
|
|
CRAY
181
DELISTED
Cray, Inc.
CRAY
| $5.59M | 0.17% |
227,290
+52,515
| +30% | +$1.31M |
|
|
ARRY
182
DELISTED
Array Biopharma Inc
ARRY
| $5.56M | 0.17% |
331,435
+99,430
| +43% | +$1.58M |
|
|
AGS
183
DELISTED
PlayAGS
AGS
| $5.54M | 0.17% |
204,550
+74,890
| +58% | +$1.75M |
|
184
A.O. Smith
AOS
$7.78B
| $5.46M | 0.17% |
92,225
-7,425
| -7% | -$468K |
|
185
SPS Commerce
SPSC
$2.95B
| $5.41M | 0.17% |
+147,238
| New | +$5.22M |
|
186
Suncor Energy
SU
$84.1B
| $5.35M | 0.16% |
131,490
+37,750
| +40% | +$1.47M |
|
187
Bio-Rad Laboratories Class A
BIO
$10.1B
| $5.33M | 0.16% |
18,490
-1,565
| -8% | -$432K |
|
188
Voya Financial
VOYA
$9.28B
| $5.29M | 0.16% |
112,605
-9,240
| -8% | -$478K |
|
189
Ezcorp Inc
EZPW
$1.86B
| $5.22M | 0.16% |
+432,890
| New | +$5.67M |
|
190
AAR Corp
AIR
$4.67B
| $5.21M | 0.16% |
112,115
-37,318
| -25% | -$1.7M |
|
|
PSXP
191
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $5.19M | 0.16% |
101,669
| – | – |
|
|
P
192
DELISTED
Pandora Media Inc
P
| $5.1M | 0.16% |
+647,620
| New | +$4.32M |
|
|
PFPT
193
DELISTED
Proofpoint, Inc.
PFPT
| $5.1M | 0.16% |
44,215
-70,514
| -61% | -$8.57M |
|
|
RDS.A
194
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $5.07M | 0.16% |
73,200
| – | – |
|
|
GTT
195
DELISTED
GTT Communications, Inc.
GTT
| $4.83M | 0.15% |
107,291
-248,766
| -70% | -$12.4M |
|
196
Biogen
BIIB
$31.9B
| $4.77M | 0.15% |
16,446
-140
| -0.8% | -$39.4K |
|
|
ANDX
197
DELISTED
Andeavor Logistics LP
ANDX
| $4.58M | 0.14% |
107,598
-38,720
| -26% | -$1.73M |
|
198
Vertex Pharmaceuticals
VRTX
$130B
| $4.56M | 0.14% |
26,830
| – | – |
|
199
Saia
SAIA
$9.41B
| $4.56M | 0.14% |
56,381
-76,459
| -58% | -$5.9M |
|
|
DNKN
200
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $4.46M | 0.14% |
64,495
-5,275
| -8% | -$339K |
|
Similar funds
MSC
BC
FEG
HCM
OH
BCM
CCI
MCM
Castleark Management's Q2 2018 Portfolio in Review
As of Q2 2018, Castleark Management held 462 positions worth $3.25B, up 2.9% from $3.16B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Castleark Management withdrew a net $180M in Q2 2018, closing 93 positions and reducing 124 holdings. Its most notable exit was Monster Beverage, an estimated $28.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Castleark Management opened a new position in Union Pacific worth $36.7M.
- Castleark Management's largest Q2 2018 buy was Union Pacific: 258,850 shares worth $36.7M.
- Castleark Management added most to Costco in Q2 2018, an estimated $36.3M increase.
- Castleark Management's biggest Q2 2018 reduction was Abiomed Inc, cutting an estimated $37.7M.
- Castleark Management fully exited Monster Beverage in Q2 2018, selling an estimated $28.2M.
- Castleark Management's ten largest holdings make up 17% of its $3.25B portfolio in Q2 2018.
- Castleark Management opened 59 new positions and closed 93 in Q2 2018.
- Castleark Management's portfolio value rose 2.9% quarter-over-quarter to $3.25B.
Based on Castleark Management's 13F filing for Q2 2018, filed 15 Aug 2018.